Skin Cancer | Topics

First-Line Nivolumab Plus Ipilimumab Improves OS Versus Chemo in Patients with Metastatic Uveal Melanoma
February 11, 2021

First-line treatment with nivolumab plus ipilimumab showed a moderate improvement in overall survival and a manageable safety profile in patients with metastatic uveal melanoma.

FDA Approves Cemiplimab as First Immunotherapy to Treat Patients With Advanced BCC
February 09, 2021

The PD-1 inhibitor cemiplimab was granted approval in patients with advanced basal cell carcinoma previously treated with a hedgehog pathway inhibitor or for whom these therapies are not appropriate.

Looking at MCC Diagnoses Over Time Reveal Varying Effects Account for Incidence Rates
January 11, 2021

A study published in JAMA Dermatology found changes in diagnostics and awareness may, in part, account for initial increases in incidence rates for Merkel cell carcinoma.